Sangamo Therapeutics Inc [SGMO] stock prices are up 29.02% to $2.64 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The SGMO shares have gain 32.25% over the last week, with a monthly amount glided 23.02%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Sangamo Therapeutics Inc [NASDAQ: SGMO] stock has seen the most recent analyst activity on December 13, 2024, when Truist upgraded its rating to a Buy but kept the price target unchanged to $7 for it. Previously, H.C. Wainwright reaffirmed its Buy rating on December 10, 2024, and kept the price target unchanged to $10. On November 03, 2023, downgrade downgraded it’s rating to Sector Perform and revised its price target to $2 on the stock. BofA Securities downgraded its rating to a Underperform and decreased its price target to $1.50 on April 28, 2023. Wedbush upgraded its rating to a Outperform but $16 remained the price target by the analyst firm on February 27, 2023. BofA Securities downgraded its rating to Neutral for this stock on January 06, 2023, and downed its price target to $5.
The stock price of Sangamo Therapeutics Inc [SGMO] has been fluctuating between $0.30 and $3.18 over the past year. Currently, Wall Street analysts expect the stock to reach $12 within the next 12 months. Sangamo Therapeutics Inc [NASDAQ: SGMO] shares were valued at $2.64 at the most recent close of the market. An investor can expect a potential return of 354.55% based on the average SGMO price forecast.
Analyzing the SGMO fundamentals
The Sangamo Therapeutics Inc [NASDAQ:SGMO] reported sales of 52.29M for trailing twelve months, representing a surge of 425.77%. Gross Profit Margin for this corporation currently stands at 0.85% with Operating Profit Margin at -2.57%, Pretax Profit Margin comes in at -2.58%, and Net Profit Margin reading is -2.58%. To continue investigating profitability, this company’s Return on Assets is posted at -1.21, Equity is -2.66 and Total Capital is -1.97. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.71.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.19 points at the first support level, and at 1.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.94, and for the 2nd resistance point, it is at 3.24.
Ratios To Look Out For
It’s worth pointing out that Sangamo Therapeutics Inc [NASDAQ:SGMO]’s Current Ratio is 1.35. Also, the Quick Ratio is 1.35, while the Cash Ratio stands at 0.91. Considering the valuation of this stock, the price to sales ratio is 11.33, the price to book ratio is 14.10.
